Morgan Stanley’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.6M Sell
2,099,451
-55,638
-3% -$900K ﹤0.01% 3129
2025
Q4
$37.1M Sell
2,155,089
-220,303
-9% -$4.27M ﹤0.01% 2375
2025
Q3
$61.2M Buy
2,375,392
+86,176
+4% +$3.26M ﹤0.01% 1843
2025
Q2
$132M Buy
2,289,216
+207,868
+10% +$16.7M 0.01% 1131
2025
Q1
$225M Sell
2,081,348
-168,160
-7% -$14.6M 0.02% 778
2024
Q4
$107M Buy
2,249,508
+211
+0% +$12.8K 0.01% 1200
2024
Q3
$221M Sell
2,249,297
-7,232
-0.3% -$934K 0.02% 775
2024
Q2
$369M Buy
2,256,529
+72,604
+3% +$10.3M 0.03% 558
2024
Q1
$333M Sell
2,183,925
-1,394,989
-39% -$232M 0.03% 591
2023
Q4
$1.12B Buy
3,578,914
+1,786,139
+100% +$646M 0.05% 352
2023
Q3
$796M Buy
1,792,775
+146,972
+9% +$66.4M 0.08% 238
2023
Q2
$713M Buy
1,645,803
+181,100
+12% +$102M 0.07% 260
2023
Q1
$870M Sell
1,464,703
-72,896
-5% -$40.8M 0.09% 219
2022
Q4
$620M Sell
1,537,599
-105,240
-6% -$49.4M 0.07% 289
2022
Q3
$962M Sell
1,642,839
-81,150
-5% -$48.6M 0.13% 159
2022
Q2
$941M Sell
1,723,989
-50,935
-3% -$25.8M 0.12% 171
2022
Q1
$1.12B Buy
1,774,924
+59,185
+3% +$30.5M 0.15% 150
2021
Q4
$1.16B Buy
1,715,739
+1,402,481
+448% +$853M 0.14% 154
2021
Q3
$205M Buy
313,258
+2,843
+0.9% +$2.43M 0.03% 522
2021
Q2
$315M Buy
+310,415
New +$272M 0.04% 391

Other funds holding AGL